文献速递消化道肿瘤与早癌消化内镜

胃癌筛查项目的参与率与产出:系统评价与Meta分析

Participation and Yield of Gastric Cancer Screening Programs: A Systematic Review and Meta-analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-04-11

该系统评价与Meta分析纳入67项研究,评估胃癌筛查项目的内镜参与率、胃癌检出率和早期胃癌检出率。合并内镜参与率为46%,胃癌检出率为0.76%,早期胃癌检出率为59%。发达国家内镜参与率和早期胃癌检出率均高于发展中国家。

要点

  • 胃癌筛查项目合并内镜参与率为46%(95%CI 41%-52%),共42项研究报告。
  • 合并胃癌检出率为0.76%(95%CI 0.55%-0.96%),共47项研究报告。
  • 合并早期胃癌检出率为59%(95%CI 49%-70%),共27项研究报告。

核心结论

  • 采用内镜参与率、胃癌检出率和早期胃癌检出率三个指标综合评估了胃癌筛查项目的参与和产出情况。

研究设计与样本

  • 系统评价与Meta分析,检索截至2023年9月20日,共纳入67项研究。
  • 采用随机效应模型计算合并估计值,并按研究时段、国家、筛查场景、当地胃癌年龄标化发病率和预筛方式进行亚组分析。

主要发现

  • 42项研究报告合并内镜参与率为46%(95%CI 41%-52%),47项研究报告合并胃癌检出率为0.76%(95%CI 0.55%-0.96%),27项研究报告合并早期胃癌检出率为59%(95%CI 49%-70%)。
  • 发达国家内镜参与率51% vs 发展中国家37%(P=0.009),发达国家早期胃癌检出率78% vs 发展中国家44%(P<0.001)。
  • 内镜参与率从2010年前的46%升至2010年后的48%(P=0.739);胃癌检出率从2010年前的0.78%降至2010年后的0.75%(P=0.905);早期胃癌检出率从2010年前的65%降至2010年后的56%(P=0.404)。
  • 多因素Meta回归分析显示,当地胃癌发病率较高与内镜参与率升高(P=0.010)和早期胃癌检出率升高(P=0.008)独立相关;日本开展的研究与内镜参与率升高(P=0.027)和早期胃癌检出率升高(P=0.002)独立相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Hundreds of gastric cancer (GC) screening programs have been launched worldwide over the past 3 decades. However, no comprehensive study evaluating the outcomes of these programs has been conducted. METHODS: This meta-analysis aimed to evaluate the temporal and geographical patterns of three key indicators in GC screening programs: endoscopic uptake rate (EUR), GC detection rate (GCDR), and early GC detection rate (EGCDR). The search was conducted until September 20, 2023. Pooled random-effect estimates of the indicators were computed, with further subgroup analysis stratified by study period, country, screening setting, local GC age-standardized incidence, and pre-screening modality. RESULTS: A total of 67 studies were included in the analysis. Of these, 42 reported an EUR of 46% (95% confidence interval [CI], 41%-52%), 47 reported a GCDR of 0.76% (95% CI, 0.55%-0.96%), and 27 reported an EGCDR of 59% (95% CI, 49%-70%). Developed countries demonstrated notably superior performance in EUR (51% vs 37%; P = .009) and EGCDR (78% vs 44%; P < .001) compared with developing countries. A gradual increase in the EUR was found, rising from 46% pre-2010 to 48% post-2010 (P = .739). In contrast, both GCDR and EGCDR exhibited a slight decline, with GCDR decreasing from 0.78% pre-2010 to 0.75% post-2010 (P = .905), and EGCDR from 65% pre-2010 to 56% post-2010 (P = .404). Multivariate meta-regression analysis revealed that a higher local GC incidence and studies conducted in Japan were independently associated with higher values of both EUR (P = .010 and P = .027, respectively) and EGCDR (P = .008 and P = .002). CONCLUSIONS: The participation and yield of GC screening programs were comprehensively assessed using 3 indicators proposed in this study.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Wang J, Zhou X, Zhu H, et al. Participation and Yield of Gastric Cancer Screening Programs: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2025. PMID: 40220843. doi:10.1016/j.cgh.2025.01.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。